NCT00490399View on ClinicalTrials.gov

Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

September 30, 2004

Conditions
Biliary Tract Carcinoma
Interventions
DRUG

gemcitabine

DRUG

cisplatin

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Seoul

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00490399 - Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas | Biotech Hunter | Biotech Hunter